TSS
EDIT icon

Two Sigma Securities’s Editas Medicine EDIT Stock Holding History

Two Sigma Securities’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,800
Closed -$827K – 1086
2020
Q4 		$827K Buy
+11,800
New +$485K 0.02% 468
2020
Q1 		– Sell
-12,200
Closed -$361K – 1594
2019
Q4 		$361K Buy
+12,200
New +$305K ﹤0.01% 1666

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Two Sigma Securities's EDIT Position: Q2 2026 in Review

Two Sigma Securities increased its Editas Medicine (EDIT) stake by 217% in Q2 2026, buying an estimated $66.3K and bringing the position to 33,138 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #1288.

Two Sigma Securities first reported a position in EDIT in Q4 2019 and has held it in 6 quarters since. The position peaked at $952K in Q4 2019. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Two Sigma Securities held 33,138 shares of Editas Medicine worth $107K as of Q2 2026.
  • Two Sigma Securities bought 22,679 Editas Medicine shares in Q2 2026, an estimated $66.3K.
  • Editas Medicine made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1288 holding.
  • Two Sigma Securities first reported a position in Editas Medicine in Q4 2019 and has held it in 6 quarters since.
  • Two Sigma Securities's Editas Medicine position peaked at $952K in Q4 2019.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.